Vanguard Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7B | Buy |
|
|||||
|
2025
Q1 | $11.4B | Buy |
|
|||||
|
2024
Q4 | $9.37B | Buy |
|
|||||
|
2024
Q3 | $10.8B | Buy |
|
|||||
|
2024
Q2 | $10.8B | Buy |
|
|||||
|
2024
Q1 | $9.48B | Buy |
|
|||||
|
2023
Q4 | $9.07B | Buy |
|
|||||
|
2023
Q3 | $7.64B | Buy |
|
|||||
|
2023
Q2 | $7.71B | Buy |
|
|||||
|
2023
Q1 | $6.88B | Buy |
|
|||||
|
2022
Q4 | $6.22B | Buy |
|
|||||
|
2022
Q3 | $6.12B | Buy |
|
|||||
|
2022
Q2 | $5.87B | Buy |
|
|||||
|
2022
Q1 | $5.34B | Buy |
|
|||||
|
2021
Q4 | $4.43B | Sell |
|
|||||
|
2021
Q3 | $3.71B | Buy |
|
|||||
|
2021
Q2 | $4.08B | Sell |
|
|||||
|
2021
Q1 | $4.39B | Sell |
|
|||||
|
2020
Q4 | $4.83B | Sell |
|
|||||
|
2020
Q3 | $5.63B | Sell |
|
|||||
|
2020
Q2 | $6.06B | Buy |
|
|||||
|
2020
Q1 | $4.9B | Buy |
|
|||||
|
2019
Q4 | $4.4B | Buy |
|
|||||
|
2019
Q3 | $3.38B | Buy |
|
|||||
|
2019
Q2 | $3.61B | Buy |
|
|||||
|
2019
Q1 | $3.58B | Buy |
|
|||||
|
2018
Q4 | $3.21B | Buy |
|
|||||
|
2018
Q3 | $3.62B | Buy |
|
|||||
|
2018
Q2 | $3.15B | Buy |
|
|||||
|
2018
Q1 | $2.99B | Buy |
|
|||||
|
2017
Q4 | $2.69B | Buy |
|
|||||
|
2017
Q3 | $2.68B | Buy |
|
|||||
|
2017
Q2 | $2.19B | Buy |
|
|||||
|
2017
Q1 | $1.8B | Buy |
|
|||||
|
2016
Q4 | $1.17B | Buy |
|
|||||
|
2016
Q3 | $1.36B | Buy |
|
|||||
|
2016
Q2 | $1.31B | Buy |
|
|||||
|
2016
Q1 | $1.19B | Buy |
|
|||||
|
2015
Q4 | $1.82B | Buy |
|
|||||
|
2015
Q3 | $1.47B | Buy |
|
|||||
|
2015
Q2 | $1.71B | Buy |
|
|||||
|
2015
Q1 | $1.59B | Sell |
|
|||||
|
2014
Q4 | $1.84B | Sell |
|
|||||
|
2014
Q3 | $1.94B | Buy |
|
|||||
|
2014
Q2 | $1.58B | Buy |
|
|||||
|
2014
Q1 | $1.16B | Buy |
|
|||||
|
2013
Q4 | $1.17B | Buy |
|
|||||
|
2013
Q3 | $1.17B | Buy |
|
|||||
|
2013
Q2 | $924M | Buy |
|